The U.S. intelligence community has declassified documents revealing a global network of more than 120 biolabs—including at least 15 in Ukraine—financed by American agencies since the Cold War. The disclosure, confirmed by U.S. officials and published this week, comes as Moscow and Washington trade accusations over biological research programs, with Kremlin-aligned figures seizing on the files to renew claims of U.S. biological warfare activity.
Why this matters now: The timing of the release—just days before the departure of Avril Haines, the outgoing U.S. director of national intelligence—raises questions about whether the declassification was a deliberate move to preempt disinformation campaigns. Meanwhile, Ukrainian officials dismiss the narrative as a Kremlin propaganda tactic, while independent experts warn the documents reveal long-standing vulnerabilities in global biosafety oversight.
What the documents show—and what they don’t
According to a classified assessment obtained by РБК-Україна and corroborated by U.S. intelligence sources, the declassified files detail a network of laboratories across 30 countries, established under programs like the Cooperative Biological Engagement Program (CBEP), which funds research on infectious diseases. Fifteen of these facilities are in Ukraine, including the State Research Center for Epidemiology and Microbiology in Kyiv, which has been a focal point of Russian disinformation for years.
Yet the documents—while providing technical details on lab infrastructure—stop short of confirming allegations that any of these facilities were involved in biological weapons development. “The labs were designed for disease surveillance and vaccine research, not weapons production,” said Dr. Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy. “But the lack of transparency around their oversight creates fertile ground for conspiracy theories—and geopolitical exploitation.”
“The real risk isn’t the labs themselves, but the information vacuum around them. When you have a narrative like ‘U.S. biolabs in Ukraine,’ it’s easy to fill in the blanks with whatever fits the agenda,” Osterholm added.
How the Kremlin weaponized the narrative
The declassification follows a pattern: just weeks before her resignation, Haines—who has publicly dismissed Russian claims of U.S. biological warfare—as reported by The New York Times, reiterated Moscow’s talking points in a closed-door briefing. The timing aligns with a 2022 disinformation campaign where Russian officials claimed Ukrainian labs were “leaking” pathogens—a claim debunked by U.S. and international inspectors.
This week, Kremlin-aligned figures like former Congresswoman Tulsi Gabbard amplified the narrative, tweeting that the declassified documents “confirm what Russia has been saying for years.” Gabbard’s comments, however, omit key context: the labs in question were established under Cooperative Threat Reduction (CTR) agreements signed by Ukraine in the 1990s, following the collapse of the Soviet Union’s biological weapons program.
“Gabbard’s framing is a classic example of selective transparency,” said Dr. Gregory Koblentz, director of the Biodefense Program at Georgetown University. “She cherry-picks the parts that fit the conspiracy while ignoring the broader history of international cooperation to prevent biological threats.”
“The real story here isn’t about Ukraine—it’s about how easily these narratives take hold when there’s no independent verification,” Koblentz added.
The global lab network: Who funds it, and why?
The U.S. has invested billions in biological research labs abroad since the 1990s, with the Cooperative Threat Reduction Program alone allocating over $1.5 billion to former Soviet states. The goal, according to declassified U.S. government documents, was to secure pathogens and expertise that could be repurposed for weapons.
Yet the program’s transparency has long been a point of contention. A 2020 report by the Nuclear Threat Initiative (NTI) found that while the labs have contributed to global pandemic preparedness—including early detection of outbreaks like SARS and H1N1—their oversight remains fragmented. “You have 120 labs in 30 countries, each with its own funding stream, safety protocols, and host-government relationships,” said Dr. Jennifer Nuzzo, director of the Johns Hopkins Center for Health Security. “That’s a recipe for gaps—and for misinformation.”
In Ukraine, the labs have played a dual role: conducting research on zoonotic diseases (like tick-borne encephalitis) while also serving as early warning systems for potential bioterrorism. But as Andriy Yurash, Ukraine’s former deputy health minister, told Інтерфакс-Україна, the war has strained their operations. “Some facilities were damaged in the early months of the invasion, and others had to relocate equipment to safer regions. The risk isn’t just theoretical—it’s operational.”
What happens next: Three scenarios
1. Geopolitical escalation: If Russia continues to leverage the narrative, it could pressure Western allies to question U.S. biosecurity programs—a move that could undermine trust in global health cooperation. “The Kremlin’s playbook is to create doubt, not just about Ukraine, but about the entire post-Cold War biosafety framework,” said Koblentz.
2. Increased scrutiny of lab oversight: The declassification may prompt calls for a unified international body to audit these facilities, similar to the IAEA’s nuclear safeguards model. “Right now, the system is reactive. We need something proactive,” Nuzzo said.
3. A shift in U.S. strategy: With Haines’ departure, the Biden administration may adopt a more defensive stance on biosecurity, focusing on transparency to preempt disinformation. “The U.S. has always been ahead of the curve on biosafety, but the curve just got steeper,” Osterholm noted.
The bottom line: Why this story isn’t just about Ukraine
The declassified documents offer a rare glimpse into a shadowy corner of global health security—but the real story is how easily truth gets lost in the noise. The labs in Ukraine, the funding from the U.S., the claims from Russia: each piece fits a larger puzzle. The question isn’t whether these labs exist. It’s whether the world can trust the systems around them—or if we’re doomed to repeat the same arguments, decade after decade.
What’s your take? Do you think the declassification will finally clear the air—or just add more fuel to the fire?
